What about vaccines? Did we run out of them? Anyway, not quite sure what to make of it, especially as the J-gov tried to push Avigan last year and that one quickly (and seemingly rightly) fizzled out.Any comments? Virusrex maybe?Game-changer as an effective "antibody booster" or intended as a simple "election-booster"? 9Ĭoncerns of the vaccine's efficacy waning over time We hear a lot about this "cocktail"-thingy since a week or so. The treatment, in which COVID-19 patients are administered casirivimab and imdevimab intravenously, lowers the risk of hospitalization or death by about 70 percent, according to overseas clinical trials. Tokura responded that he will notify the lobby's members of the request, telling reporters after the meeting that he also urged Suga to make "antibody cocktail" treatment widely available. You have to love how the government comes up with figures (here: 70%) but nobody has a clue where they get these from. Our friend Covid must be shaking in its boots. You got to love the fact that Kyodo, Jiji and Sankei boast about the 50%-line, but do keep under wraps that full vaccination is still limping at somewhere in the 30s percents.Can't blame them, there is an election coming up and things don't look good for the "crack-team" running the show.Īlso Wednesday, Suga asked Japan's largest business lobby to allow employees to work from home a day after calling on firms to reduce the number of commuters by 70 percent.
0 kommentar(er)
